Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
|
| gptkbp:affects |
quality of life
social interactions muscle strength daily activities work ability |
| gptkbp:associated_with |
thymoma
hyperplasia of the thymus |
| gptkbp:can_lead_to |
respiratory failure
myasthenic crisis |
| gptkbp:caused_by |
autoimmune response
|
| gptkbp:diagnosis |
gptkb:MRI
CT scan clinical examination serological tests electromyography |
| gptkbp:difficulty_levels |
older patients
|
| gptkbp:first_described_by |
1895
|
| https://www.w3.org/2000/01/rdf-schema#label |
Myasthenia gravis
|
| gptkbp:is_associated_with |
other autoimmune diseases
|
| gptkbp:is_characterized_by |
fatigue
fluctuating muscle weakness |
| gptkbp:is_common_in |
gptkb:women
young adults men older adults |
| gptkbp:is_considered |
chronic condition
|
| gptkbp:is_less_severe_in |
younger patients
|
| gptkbp:is_managed_by |
physical therapy
lifestyle changes medication adherence intravenous immunoglobulin neurologists plasmapheresis specialists in autoimmune diseases |
| gptkbp:is_studied_in |
gptkb:medical_research
clinical trials |
| gptkbp:is_targeted_at |
gptkb:disease
gptkb:surgery stress certain medications |
| gptkbp:is_treatable |
gptkb:true
|
| gptkbp:prevalence |
1 in 5,000 people
|
| gptkbp:replaced_by |
gptkb:true
|
| gptkbp:research_focus |
genetic factors
treatment efficacy pathophysiology thymus gland autoantibodies |
| gptkbp:symptoms |
muscle weakness
diplopia ptosis |
| gptkbp:treatment |
immunosuppressants
anticholinesterase medications thymectomy |
| gptkbp:bfsParent |
gptkb:Scopace
|
| gptkbp:bfsLayer |
5
|